Valerie J. Reed, ARNP

Valerie Reed practices at Sequim Health & Rehabilitation Center in Sequim, Washington.

Valerie Reed's NPI, 1730133638, was assigned on May 22, 2006. Valerie Reed holds Washington license AP60377133.

Valerie Reed's primary practice is Sequim Health & Rehabilitation Center, at 103 W Cedar St, Sequim, WA 98382 in Clallam County. The practice phone is (360) 582-2400.

Valerie Reed's primary practice is Sequim Health & Rehabilitation Center in Sequim, Washington. Valerie Reed is also affiliated with St. Michael Medical Center. The medical group on file is Post Acute Medical. Dmand AI also links Valerie Reed to 1 more hospital, 7 medical groups, 4 group practices and clinics, 2 home health agencies and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Valerie Reed practices, 9 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Valerie Reed's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Valerie Reed's licenses on file in 2 states: Washington and New York.

CMS counts 587 Medicare patients who saw Valerie Reed in 2024. The largest group is 75 to 84, with 233 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Valerie Reed's median patient age at 80, with 63% women.

In 2024, Valerie Reed wrote 11,389 Medicare Part D claims for 452 patients. 88% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Valerie Reed for performance year 2024, reported through an alternative payment model (APM). Valerie Reed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Valerie Reed from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $108.